Epigenetic Pathways and Glioblastoma Treatment: Insights from Signaling Cascades

Bryce K. Allen, Vasileios Stathias, Marie E. Maloof, Dusica Vidovic, Emily F. Winterbottom, Anthony J Capobianco, Jennifer Clarke, Stephan C Schuerer, David J Robbins, Nagi Ayad

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

There is an urgent need to identify novel therapies for glioblastoma (GBM) as most therapies are ineffective. A first step in this process is to identify and validate targets for therapeutic intervention. Epigenetic modulators have emerged as attractive drug targets in several cancers including GBM. These epigenetic regulators affect gene expression without changing the DNA sequence. Recent studies suggest that epigenetic regulators interact with drivers of GBM cell and stem-like cell proliferation. These drivers include components of the Notch, Hedgehog, and Wingless (WNT) pathways. We highlight recent studies connecting epigenetic and signaling pathways in GBM. We also review systems and big data approaches for identifying patient specific therapies in GBM. Collectively, these studies will identify drug combinations that may be effective in GBM and other cancers. J. Cell. Biochem. 116: 351-363, 2015.

Original languageEnglish (US)
Pages (from-to)351-363
Number of pages13
JournalJournal of Cellular Biochemistry
Volume116
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

DNA sequences
Cell proliferation
Drug Combinations
Glioblastoma
Epigenomics
Gene expression
Modulators
Pharmaceutical Preparations
Therapeutics
Regulator Genes
Information Systems
Big data
Neoplasms
Stem Cells
Cell Proliferation
Gene Expression

Keywords

  • EPIGENETICS
  • GLIOBLASTOMA
  • HEDGEHOG
  • NOTCH
  • SIGNALING PATHWAYS
  • WINGLESS

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Epigenetic Pathways and Glioblastoma Treatment : Insights from Signaling Cascades. / Allen, Bryce K.; Stathias, Vasileios; Maloof, Marie E.; Vidovic, Dusica; Winterbottom, Emily F.; Capobianco, Anthony J; Clarke, Jennifer; Schuerer, Stephan C; Robbins, David J; Ayad, Nagi.

In: Journal of Cellular Biochemistry, Vol. 116, No. 3, 01.03.2015, p. 351-363.

Research output: Contribution to journalArticle

Allen, Bryce K. ; Stathias, Vasileios ; Maloof, Marie E. ; Vidovic, Dusica ; Winterbottom, Emily F. ; Capobianco, Anthony J ; Clarke, Jennifer ; Schuerer, Stephan C ; Robbins, David J ; Ayad, Nagi. / Epigenetic Pathways and Glioblastoma Treatment : Insights from Signaling Cascades. In: Journal of Cellular Biochemistry. 2015 ; Vol. 116, No. 3. pp. 351-363.
@article{7cc91aef11974c5f83a2ca60685d75f7,
title = "Epigenetic Pathways and Glioblastoma Treatment: Insights from Signaling Cascades",
abstract = "There is an urgent need to identify novel therapies for glioblastoma (GBM) as most therapies are ineffective. A first step in this process is to identify and validate targets for therapeutic intervention. Epigenetic modulators have emerged as attractive drug targets in several cancers including GBM. These epigenetic regulators affect gene expression without changing the DNA sequence. Recent studies suggest that epigenetic regulators interact with drivers of GBM cell and stem-like cell proliferation. These drivers include components of the Notch, Hedgehog, and Wingless (WNT) pathways. We highlight recent studies connecting epigenetic and signaling pathways in GBM. We also review systems and big data approaches for identifying patient specific therapies in GBM. Collectively, these studies will identify drug combinations that may be effective in GBM and other cancers. J. Cell. Biochem. 116: 351-363, 2015.",
keywords = "EPIGENETICS, GLIOBLASTOMA, HEDGEHOG, NOTCH, SIGNALING PATHWAYS, WINGLESS",
author = "Allen, {Bryce K.} and Vasileios Stathias and Maloof, {Marie E.} and Dusica Vidovic and Winterbottom, {Emily F.} and Capobianco, {Anthony J} and Jennifer Clarke and Schuerer, {Stephan C} and Robbins, {David J} and Nagi Ayad",
year = "2015",
month = "3",
day = "1",
doi = "10.1002/jcb.24990",
language = "English (US)",
volume = "116",
pages = "351--363",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Epigenetic Pathways and Glioblastoma Treatment

T2 - Insights from Signaling Cascades

AU - Allen, Bryce K.

AU - Stathias, Vasileios

AU - Maloof, Marie E.

AU - Vidovic, Dusica

AU - Winterbottom, Emily F.

AU - Capobianco, Anthony J

AU - Clarke, Jennifer

AU - Schuerer, Stephan C

AU - Robbins, David J

AU - Ayad, Nagi

PY - 2015/3/1

Y1 - 2015/3/1

N2 - There is an urgent need to identify novel therapies for glioblastoma (GBM) as most therapies are ineffective. A first step in this process is to identify and validate targets for therapeutic intervention. Epigenetic modulators have emerged as attractive drug targets in several cancers including GBM. These epigenetic regulators affect gene expression without changing the DNA sequence. Recent studies suggest that epigenetic regulators interact with drivers of GBM cell and stem-like cell proliferation. These drivers include components of the Notch, Hedgehog, and Wingless (WNT) pathways. We highlight recent studies connecting epigenetic and signaling pathways in GBM. We also review systems and big data approaches for identifying patient specific therapies in GBM. Collectively, these studies will identify drug combinations that may be effective in GBM and other cancers. J. Cell. Biochem. 116: 351-363, 2015.

AB - There is an urgent need to identify novel therapies for glioblastoma (GBM) as most therapies are ineffective. A first step in this process is to identify and validate targets for therapeutic intervention. Epigenetic modulators have emerged as attractive drug targets in several cancers including GBM. These epigenetic regulators affect gene expression without changing the DNA sequence. Recent studies suggest that epigenetic regulators interact with drivers of GBM cell and stem-like cell proliferation. These drivers include components of the Notch, Hedgehog, and Wingless (WNT) pathways. We highlight recent studies connecting epigenetic and signaling pathways in GBM. We also review systems and big data approaches for identifying patient specific therapies in GBM. Collectively, these studies will identify drug combinations that may be effective in GBM and other cancers. J. Cell. Biochem. 116: 351-363, 2015.

KW - EPIGENETICS

KW - GLIOBLASTOMA

KW - HEDGEHOG

KW - NOTCH

KW - SIGNALING PATHWAYS

KW - WINGLESS

UR - http://www.scopus.com/inward/record.url?scp=84943522699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943522699&partnerID=8YFLogxK

U2 - 10.1002/jcb.24990

DO - 10.1002/jcb.24990

M3 - Article

C2 - 25290986

AN - SCOPUS:84943522699

VL - 116

SP - 351

EP - 363

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 3

ER -